“…By solvent evaporation, PEG in combination with poly(anhydride esters) (PAE) (Lv et al, 2013) and poly(lactic acid) (PLA) carried out to micelles employed as CUR vehicle in HeLa (Lv et al, 2013) in vitro and in MCF-7 cancer cells with considerable results in xenograft mouse model in synergism with DOX . In different studies including in vitro (Gou et al, 2015) or in vivo cancer models, PEG-PCL micelles prepared by self-assembly or thin layer evaporation were proposed for the treatment of ovarian (Gou et al, 2015) and breast (Zhu et al, 2015) cancer cells, breast (Liu et al, 2013), cervical (Mikhail et al, 2014), colon (Mikhail et al, 2014), and lung (Gong et al, 2013;Wang et al, 2013) xenograft mouse model, showing anti-angiogenesis properties in zebrafish (Gong et al, 2013;Wang et al, 2013). A further modification of PEG-PCL micelles by introduction of fatty acids residues (e.g.…”